
About iScreen Vision
iScreen Vision is a Healthcare company based in Memphis (United States) founded in 2009. Pediatric vision screening devices and analysis are provided. It operates in the Healthcare and Technology sectors. iScreen Vision has raised $7.47 million across 3 funding rounds from investors including MB Venture Partners and Innova Memphis. Its focus areas include Life Sciences, Neurology, Medical Devices and Screening Devices. Its competitors include NeuroKaire, C. Light Technologies and Rhaeos; 3 of its 3 listed competitors have raised funding.
Company details
iScreen Vision is a medical device company offering vision screening devices and analysis to the pediatric market. Using its patented technology for digital photoscreening for pediatric vision problems, including refractive errors such as myopia, hyperopia, astigmatism and anisometropia; eye alignment problems, such as strabismus; anisocoria, ptosis; and media opacities such as cataracts. According to the company, digital photoscreening doesnt require a patient response, hence, useful for vision screening of non-verbal, non-compliant, and developmentally challenged children.
- Headquarters Memphis, United States
- SectorsHealthcareTechnology
- Website iscreenvision.com
- Social LinkedIn X Facebook
- Total Equity Funding$7.47M (USD)
in 3 rounds
- Latest Funding Round$187.65K (USD), Series B
Oct 2014
- InvestorsMB Venture Partners
& 1 more
Funding Insights of iScreen Vision
iScreen Vision has successfully raised a total of $7.47M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $187.65 thousand completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.47M
- Total Rounds 3
- Last Round Series B β $187,645
- First Round $3.28M
(Mar 2011)
- Investors Count 2
All 3 funding rounds of iScreen Vision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2014 | $187,645 | Series B | β | β | β |
| Sep 2013 | $4M | Series B | β | MB Venture Partners | |
| Mar 2011 | $3.28M | Series A | β | Innova Memphis | β |
2 investors in total: 2 institutional.
Investors in iScreen Vision
iScreen Vision has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include MB Venture Partners and Innova Memphis.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Capital and strategic direction are provided to life science companies. | mbventures.com | Memphis, United States | ||
Early-stage investments are made in high-growth technology companies. | innovamemphis.com | Memphis, United States |
Investor details for iScreen Vision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of iScreen Vision
15 people are tracked at iScreen Vision (3 in leadership, 5 in board & advisors, 7 in team).
| Name | Role | Group |
|---|---|---|
Jimmy Clinton | Contract CFO | Leadership |
Lisa Watson | Director, Operations | Leadership |
Buck Brown | Chief Executive Officer | Leadership |
Gary Stevenson | Director | Board & advisors |
Jan Bouten | Director | Board & advisors |
Ross A. Kennedy | Director | Board & advisors |
William Martin | Director | Board & advisors |
John W. Stokes Jr. | Director | Board & advisors |
Elizabeth McManus | Analyst | Team |
Don Carmon | CIO | Team |
Erinn Enke | Analyst | Team |
Gayle Roberts | Analyst | Team |
Marla Shainberg | Analyst | Team |
Joy Nichols | Customer Service Representative | Team |
Wanda Pfeifer | Analyst | Team |
Complete people profiles for iScreen Vision
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of iScreen Vision
3 dated milestones of iScreen Vision across 5 years, from founding to its latest funding, stage changes and deals.
- Founded iScreen Vision is founded.
- Funding First funding round of $3.3M.
- Funding Latest funding round, Series B, of $188K.
Competitors of iScreen Vision
iScreen Vision has 3 listed competitors in our database, 3 of them funded. They include NeuroKaire, C. Light Technologies and Rhaeos.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neurokaire.com | 2017 | Kearny, United States | $20M | Platform offering personalized treatment for psychiatric and neurological conditions | ||
| clighttechnologies.com | 2014 | Berkeley, United States | $2.5M | Eye-tracking devices are developed for neurodegenerative disease monitoring. | ||
| rhaeos.com | 2018 | Evanston, United States | $12.8M | 10 | Noninvasive device developed for CSF monitoring and hydrocephalus management. |
Detailed competitors of iScreen Vision
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of iScreen Vision
The website of iScreen Vision (iscreenvision.com) receives about 2.8K visits a month.
- Monthly visits2.8K
▲ 5.1% vs previous month
Websites whose visitors overlap most with iScreen Vision. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
chipsblog.pcc.com | chipsblog.pcc.com | 100% | β | ||
rebuildyourvision.com | rebuildyourvision.com | 90% | #1,959,490 | β | |
provisu.ch | provisu.ch | 90% | β | ||
eyeexamonline.com | eyeexamonline.com | 90% | β | ||
eyeglassguide.com | eyeglassguide.com | 90% | β | ||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 12 similar websites and full traffic analytics for iScreen Vision
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Ophthalmology
3 companies that operate in the same segment as iScreen Vision (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about iScreen Vision
iScreen Vision was founded in 2009 and raised its 1st funding round 2 years after it was founded.
iScreen Vision is headquartered in Memphis, United States. It is registered at Memphis, Tennessee, United States.
iScreen Vision is a funded company, having raised a total of $7.47M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.28M, raised on Mar 2011.
iScreen Vision is a medical device company offering vision screening devices and analysis to the pediatric market. Using its patented technology for digital photoscreening for pediatric vision problems, including refractive errors such as myopia, hyperopia, astigmatism and anisometropia; eye alignment problems, such as strabismus; anisocoria, ptosis; and media opacities such as cataracts. According to the company, digital photoscreening doesnt require a patient response, hence, useful for vision screening of non-verbal, non-compliant, and developmentally challenged children.
iScreen Vision's top competitors include NeuroKaire, Rhaeos and C. Light Technologies.
iScreen Vision has 2 investors. Key investors include MB Venture Partners, and Innova Memphis.